GSGRX
Price
$43.95
Change
+$0.27 (+0.62%)
Updated
Apr 23 closing price
Net Assets
375.17M
VIVAX
Price
$63.78
Change
+$0.44 (+0.69%)
Updated
Apr 23 closing price
Net Assets
190.51B
Ad is loading...

GSGRX vs VIVAX

Header iconGSGRX vs VIVAX Comparison
Open Charts GSGRX vs VIVAXBanner chart's image
Goldman Sachs Equity Income A
Price$43.95
Change+$0.27 (+0.62%)
VolumeN/A
Net Assets375.17M
Vanguard Value Index I
Price$63.78
Change+$0.44 (+0.69%)
VolumeN/A
Net Assets190.51B
GSGRX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSGRX vs. VIVAX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSGRX is a Buy and VIVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 191B vs. GSGRX (375M). VIVAX pays higher dividends than GSGRX: VIVAX (2.14) vs GSGRX (1.26). GSGRX was incepted earlier than VIVAX: GSGRX (32 years) vs VIVAX (32 years). GSGRX (1.20) is less costly to investors than VIVAX (0.17). GSGRX is a more actively managed with annual turnover of: 31.00 vs. VIVAX (10.00). GSGRX has a lower initial minimum investment than VIVAX: GSGRX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 2.68 vs. GSGRX (-3.07). VIVAX return over 5 years is better than : 68.72 vs. GSGRX (39.68).
GSGRXVIVAXGSGRX / VIVAX
Total Expense Ratio1.000.17588%
Annual Report Gross Expense Ratio1.200.17706%
Fund Existence32 years32 years-
Gain YTD-3.924-4.09296%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets375M191B0%
Annual Yield % from dividends1.262.1459%
Returns for 1 year-3.072.68-115%
Returns for 3 years2.3211.9619%
Returns for 5 years39.6868.7258%
Returns for 10 years50.3490.3756%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.230.07
+3.24%
GT Biopharma
BHR1.890.04
+2.16%
Braemar Hotels & Resorts
CRK18.480.26
+1.43%
Comstock Resources
CASS40.650.22
+0.54%
Cass Information Systems
KIM20.510.06
+0.29%
Kimco Realty Corp